Plus Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.37

+0.08 (+1.86%)

As of Jun 30, 10:41 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +169.3% upside

Low Target $8.46

Average Target $11.77

High Target $14.40

Current Price $4.37

Current
$4.37

Target
$11.77

$8.46 $11.77 avg $14.40

Scenario Analysis

Bear Case

$8.46

93.6%

Low target

Base Case

$11.77

+169.3%

Avg target

Bull Case

$14.40

+229.5%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$23.43

-81.3% from high

52-Week Low

$2.90

+50.7% from low

Target vs 52W High

$11.77

-49.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%